Chongqing Pharscin Pharmaceutical Co., Ltd.
Shenzhen Stock Exchange 002907.SZ
Chongqing Pharscin Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) on January 27, 2025: 3.10
Chongqing Pharscin Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) is 3.10 on January 27, 2025, a -14.44% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
Chongqing Pharscin Pharmaceutical Co., Ltd. 52-week high Price to Book Ratio (P/B) is 3.97 on May 14, 2024, which is 27.96% above the current Price to Book Ratio (P/B).
-
Chongqing Pharscin Pharmaceutical Co., Ltd. 52-week low Price to Book Ratio (P/B) is 2.68 on February 05, 2024, which is -13.60% below the current Price to Book Ratio (P/B).
-
Chongqing Pharscin Pharmaceutical Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 3.37.
Key data
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Don’t Miss A Beat
Shenzhen Stock Exchange: 002907.SZ
| CEO | Ms. Xiaoying Liu |
| IPO Date | Oct. 20, 2017 |
| Location | China |
| Headquarters | No. 89, Middle Sec of Huangshan Ave |
| Employees | 1,411 |
| Sector | Healthcare |
| Industries | |
Description
Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.
Key trends
Past 5 years
StockViz Staff
February 3, 2025
Any question? Send us an email